Tweet** CJC-1295 **
(here's the official Title + conclusion from the research article listed above)
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295,
a long-acting analog of GH-releasing hormone, in healthy adults.
J Clin Endocrinol Metab. 2006 Mar;91(3):799-805. Epub 2005 Dec 13.
CONCLUSIONS: Subcutaneous administration of CJC-1295 resulted in sustained, dose-dependent increases in GH and IGF-I levels in healthy adults and was safe and relatively well tolerated, particularly at doses of 30 or 60 microg/kg. There was evidence of a cumulative effect after multiple doses. These data support the potential utility of CJC-1295 as a therapeutic agent.
Reply With Quote